[1] |
ZHAO Shifeng, SONG Xiangming, YAO Jianping.
Tirzepatide: A new glucagon-like peptide-1 receptor/glucose-dependent insulinotropic peptide receptor dual agonist
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 220-227.
|
[2] |
QUAN Haiyan, JIANG Xing, HE Lu.
Recent progress of mitophagy in hepatic insulin resistance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 198-204.
|
[3] |
WANG Chunjiang,SUN Wei,SUN Linli.
Clinical characteristics of insulin autoimmune syndrome caused by methimazole in Chinese population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(2): 209-213.
|
[4] |
LIU Huanmiao, CHEN Zhuohui, WU Di, HUANG Xueting, WAN Qiquan.
Insulin attenuates the inhibition effect of lipopolysaccharide on Na+-K+-ATPase α1 via PI3K/AKT and PI3K/ERK pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(8): 896-902.
|
[5] |
QUAN Haiyan, LIU Yuhuan, YANG Li, YANG Fang, QIN Xuping.
Improvement of CGRP on vascular endothelial cells insulin resistance via activation of cAMP/PPARγ/eNOS pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(6): 615-622.
|
[6] |
CHEN Yan, ZHU Lijun, FANG Zhengmei, ZHU Hui, JIN Yuelong, SHEN Chong, YAO Yingshui.
Association of insulin-like growth factor(IGF)-1 polymorphisms and efficacy of antihypertensive drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(2): 171-179.
|
[7] |
DING Fan, LI Wenxiong, ZHANG Jiali, ZHANG Yan.
Research progress on pathology mechanism and treatment target for diabetic sarcopenia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(12): 1428-1433.
|
[8] |
ZHENG Li, MO Juanfen, WU Jiayuan, GUO Li, BAO Yi.
Study on the anti-hyperlipidemia mechanisms and signaling pathways of traditional Chinese medicine Polygonum cuspidatum based on network pharmacology
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(10): 1107-1119.
|
[9] |
SONG Meiqing.
Effect of metformin on bone mineral density, insulin resistance and cytokines in type 2 diabetes mellitus patients with primary hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(6): 694-698.
|
[10] |
SHEN Ji-zhong, LIU Hang.
Experimental study of a metabolic syndrome mouse model induced by high sucrose-containing drinking water
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(9): 1011-1015.
|
[11] |
WEI You-quan, CAO Heng.
Effects of recombinant human insulin-like growth factor-Ι on the expression of matrix metalloproteinases and interstitial degradation of myocardial infarction rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(8): 866-871.
|
[12] |
ZOU Liu-yi, WANG Mei-rong, NI Lian-song.
Effects of ketotifen on insulin resistance in high-carbon hydrate-fat diet rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(7): 761-765.
|
[13] |
QIAN Su-bo, CHEN Mu, SHEN Hai-bo, QI Jun.
Effects of shRNA targeting IGF2 gene on the growth and cell cycle of human bladder cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(11): 1233-1237.
|
[14] |
RUAN Guan-yu, XU Qiu-xing, CAI Hui-ya, DENG Jie, SHI Dao-hua.
Comparison of neonatal outcomes in women with gestational diabetes mellitus treated with metformin or insulin: a systematic review
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(10): 1139-1143.
|
[15] |
HE Lei, GUO Cen, YAO Dan, SHENG Jing-jing, PAN Guo-yu, LIU Xiao-dong.
Effects of glucose and insulin on expression and function of bile acid transporters in sandwich cultured rat hepatocytes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(8): 847-852.
|